Related Experiment Video
Updated: Jul 5, 2025

Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
Published on: January 3, 2012
The Chaperonin TRiC/CCT Inhibitor HSF1A Protects Cells from Intoxication with Pertussis Toxin
Jinfang Jia1, Manuel Zoeschg1, Holger Barth1
1Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany.
Insights
The chaperonin TRiC/CCT inhibitor, HSF1A, protects cells from pertussis toxin (PT) by reducing its ADP-ribosylation activity. This study reveals a novel interaction and suggests HSF1A as a therapeutic strategy against whooping cough.
Area of Science:
- Microbiology
- Cellular Biology
- Toxicology
Background:
- Pertussis toxin (PT) from *Bordetella pertussis* causes whooping cough.
- The chaperonin TRiC/CCT complex is crucial for protein folding and homeostasis.
- TRiC/CCT is implicated in the activity of other bacterial toxins like *Clostridioides difficile* TcdB.
Purpose of the Study:
- To investigate the protective effects of the TRiC/CCT inhibitor HSF1A against PT-induced cell intoxication.
- To elucidate the mechanism by which HSF1A confers protection against PT.
- To explore potential therapeutic applications of HSF1A for pertussis.
Main Methods:
- Treatment of cells with PT and HSF1A.
- Assay for ADP-ribosylated Gαi levels.
- In vitro enzyme activity and cellular binding assays for PT.
- Investigation of PTS1 interaction with CCT5.
- Measurement of cAMP signaling pathways.
Main Results:
- HSF1A significantly reduced ADP-ribosylated Gαi levels in PT-treated cells.
- HSF1A did not affect PT's enzymatic activity or cellular binding.
- A novel interaction between PTS1 and CCT5 was identified, with reduced signaling upon HSF1A treatment.
- HSF1A mitigated PT-induced disruptions in cellular cAMP signaling.
Conclusions:
- HSF1A demonstrates protective effects against pertussis toxin-induced cellular damage.
- The findings suggest a novel mechanism involving TRiC/CCT and PTS1 in PT intoxication.
- HSF1A represents a potential therapeutic lead for combating pertussis toxin pathogenicity.
Abstract:
Pertussis toxin (PT) is a bacterial AB5-toxin produced by Bordetella pertussis and a major molecular determinant of pertussis, also known as whooping cough, a highly contagious respiratory disease. In this study, we investigate the protective effects of the chaperonin TRiC/CCT inhibitor, HSF1A, against PT-induced cell intoxication. TRiC/CCT is a chaperonin complex that facilitates the correct folding of proteins, preventing misfolding and aggregation, and maintaining cellular protein homeostasis. Previous research has demonstrated the significance of TRiC/CCT in the functionality of the Clostridioides difficile TcdB AB-toxin. Our findings reveal that HSF1A effectively reduces the levels of ADP-ribosylated Gαi, the specific substrate of PT, in PT-treated cells, without interfering with enzyme activity in vitro or the cellular binding of PT. Additionally, our study uncovers a novel interaction between PTS1 and the chaperonin complex subunit CCT5, which correlates with reduced PTS1 signaling in cells upon HSF1A treatment. Importantly, HSF1A mitigates the adverse effects of PT on cAMP signaling in cellular systems. These results provide valuable insights into the mechanisms of PT uptake and suggest a promising starting point for the development of innovative therapeutic strategies to counteract pertussis toxin-mediated pathogenicity.
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Cotranslational Protein Translocation
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Pinching-off of Coated Vesicles

